Screening of Egyptian toddlers for autism spectrum disorder using an Arabic validated version of M-CHAT; report of a community-based study (Stage I)

详细信息    查看全文

• 作者：F.E. Mohamed^a ; E.A. Zaky^a ; ^{emanzaky@med.asu.edu.eg" class="auth_mail" title="E-mail the corresponding author} ; A. Youssef^a ; R. Elhossiny^a ; S. Zahra^a ; R. Khalaf^a ; W. Youssef^a ; A. Wafiq^a ; R. Ibrahim^a ; R. Abd-Elhakim^a ; A. Obada^a ; W.S. Eldin^b
• 关键词：M-CHAT ; Arabic validated version of M-CHAT ; Autism spectrum disorder (ASD) ; Childhood Autism Rating Scale (CARS)
• 刊名：European Psychiatry
• 出版年：2016
• 出版时间：April 2016
• 年：2016
• 卷：34
• 期：Complete
• 页码：43-48
• 全文大小：872 K

文摘

Although there is a recommendation that toddlers be screened for Autism spectrum disorder (ASD) during their 18- and 24-month well-care child visits, diagnosis often occurs well after the child turns 4 years old. Such delayed diagnosis hinders the implementation of early intervention thus worsens the long-term prognosis of ASD.

Objective

The current community-based study in its stage I aimed at early screening of Egyptian toddlers for ASD using an Arabic validated version of Modified Checklist for Autism in Toddlers (M-CHAT).

Methodology

A cross-sectional community-based descriptive study was carried out enrolling 5546 Egyptian toddlers. They were randomly recruited from those attending Primary Health Care Units in six Egyptian governorates with a fair representation of the urban, semi-urban, and rural Egyptian populations. An Arabic validated version of M-CHAT was used as a screening tool for ASD.

Results

The current study revealed failure of M-CHAT (suspected to have ASD and needs further evaluation) in 1320 out of the enrolled 5546 Egyptian toddlers (23.8%).

Conclusion

M-CHAT as a screening tool for ASD has flagged a considerable percent of the enrolled toddlers that necessitates referral for further evaluation (stage II) to settle the diagnosis of ASD in the true positive cases. Perfecting the delicate balance between sensitivity and specificity for ASD screening tools is crucial in order not to miss early detection of ASD cases and at the same time, to avoid over-diagnosis with subsequent abuse of the limited healthcare resources in developing countries.